Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex.

Turbyfill KR, Clarkson KA, Vortherms AR, Oaks EV, Kaminski RW.

mSphere. 2018 Mar 28;3(2). pii: e00583-17. doi: 10.1128/mSphere.00583-17. eCollection 2018 Mar-Apr.

2.

Improving chances for successful clinical outcomes with better preclinical models.

Wenzel H, Kaminski RW, Clarkson KA, Maciel M Jr, Smith MA, Zhang W, Oaks EV.

Vaccine. 2017 Dec 14;35(49 Pt A):6798-6802. doi: 10.1016/j.vaccine.2017.08.030. Epub 2017 Sep 7.

3.

Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study.

Riddle MS, Kaminski RW, Di Paolo C, Porter CK, Gutierrez RL, Clarkson KA, Weerts HE, Duplessis C, Castellano A, Alaimo C, Paolino K, Gormley R, Gambillara Fonck V.

Clin Vaccine Immunol. 2016 Dec 5;23(12):908-917. Print 2016 Dec.

4.

Life on dialysis: a lived experience.

Clarkson KA, Robinson K.

Nephrol Nurs J. 2010 Jan-Feb;37(1):29-35.

PMID:
20333901
5.

Technic of darkfield examination.

CLARKSON KA.

Med Techn Bull. 1956 Sep-Oct;7(5):199-202. No abstract available.

PMID:
13368842

Supplemental Content

Loading ...
Support Center